-
PHASQ Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
PhaseBio Pharmaceuticals (PHASQ)
Company Profile
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.80 mm | 7.80 mm | 7.80 mm | 7.80 mm | 7.80 mm | 7.80 mm |
Cash burn (monthly) | 3.63 mm | 4.72 mm | 8.44 mm | 9.88 mm | 3.47 mm | 4.95 mm |
Cash used (since last report) | 108.09 mm | 140.65 mm | 251.37 mm | 294.38 mm | 103.39 mm | 147.52 mm |
Cash remaining | -100.28 mm | -132.85 mm | -243.56 mm | -286.58 mm | -95.59 mm | -139.72 mm |
Runway (months of cash) | -27.6 | -28.1 | -28.9 | -29.0 | -27.5 | -28.2 |
13F holders | Current |
---|---|
Total holders | 49 |
Opened positions | 6 |
Closed positions | 14 |
Increased positions | 12 |
Reduced positions | 13 |
13F shares | Current |
---|---|
Total value | 15.93 mm |
Total shares | 24.11 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
NEA Management | 6.64 mm | $3.99 mm |
Avidity Partners Management | 4.41 mm | $2.64 mm |
Rock Springs Capital Management | 2.77 mm | $1.67 mm |
Vanguard | 1.81 mm | $1.09 mm |
MAI Capital Management | 1.71 mm | $1.02 mm |
JNJ Johnson & Johnson | 1.61 mm | $964.00 k |
CHI Advisors | 750.00 k | $450.00 k |
Rosalind Advisors | 707.47 k | $1.85 mm |
BLK BlackRock | 684.20 k | $411.00 k |
SF Stifel Financial | 439.27 k | $264.00 k |